Nuevolution discovery platform earns $2m from Novartis; new twist in patent case against ex CSO
Nuevolution has been paid a $2m (€1.8m) milestone by drug discovery platform licensee Novartis.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs